Written by Mariyam Sara
Published on May 14, 2026 | 6 min read
The Nifty Pharma index is a sectoral benchmark index that tracks the performance of the top 20 companies in the pharmaceutical sector listed on the NSE.
The Nifty Pharma index is determined by using the free float market capitalisation method, where the index value reflects the total free float market value of all the stocks relative to the base market capitalisation value.
The constituents of the Nifty Pharma index are selected based on the eligibility criteria set by the NSE Indices Ltd.
You can invest in the Nifty Pharma index by directly buying the individual stocks or through index funds and ETFs.
Before investing in the Nifty Pharma index, consider risks arising from regulatory changes, currency fluctuations, research and development (R&D) failures, and investment concentration.
India’s pharmaceutical industry is considered a defensive sector since the demand for medicines and healthcare products generally remains steady regardless of the economic conditions. The Nifty Pharma index acts as a barometer for the Indian pharmaceutical sector and reflects the true performance of the sector.
Let’s understand what the Nifty Pharma index is, how it works, and whether it is the right investment for you.
The Nifty Pharma index is a sectoral benchmark index that tracks the performance of the top 20 pharmaceutical companies listed on NSE. These companies are selected based on the eligibility criteria set by the NSE Indices Ltd. The Nifty Pharma index is widely used as a benchmark for fund portfolios, launching of index funds and ETFs, along with other pharma-related investment products.
The Nifty Pharma index works by using the free float market capitalisation methodology, where the index value reflects the total free float market value of all the stocks relative to the base market capitalisation value.
The constituent companies of the Nifty Pharma index are selected based on the following criteria.
The companies should be a part of the Nifty 500 at the time of review. If the number of eligible stocks for the index within Nifty 500 falls below 20, then the deficit number of the stocks must be ranked within the top 800 based on both average daily turnover and average daily full market capitalisation, calculated based on the past six months' period data considered during the Nifty 500 index rebalancing.
The companies should be a part of the pharmaceutical sector.
The company's trading frequency should be at least 90% in the last six months.
The Company should have a minimum listing history of 1 month as of the cutoff date.
The final selection of 20 companies shall be done based on the free-float market capitalisation of the companies. Companies that are available for trading in NSE’s Futures & Options segment shall be given preference at the time of final selection.
The weightage of each stock in the index is calculated based on its free-float market capitalisation. The weight of the single stock is capped at 33%, and the total weightage of the top 3 stocks should not be more than 62% at the time of rebalancing.
The Nifty Pharma index is rebalanced semi-annually, with companies that no longer meet the eligibility criteria being replaced to ensure the index accurately reflects the performance of the pharmaceutical sector.
You can invest in the Nifty Pharma index through the following methods.
You can invest directly in the individual stocks listed in the Nifty Pharma Index. However, this would require strong fundamental research and would increase dependency on a single company or a few pharma stocks.
If you prefer a passive approach, you can invest in Index funds that replicate the Nifty Pharma index. These funds offer diversified exposure and allow you to invest via SIPs (Systematic Investment Plan).
Similar to index funds, ETFs also replicate the Nifty Pharma index to offer exposure to the top 20 companies included in the index. ETFs are listed on the stock exchanges and offer smooth trading.
Over the last 5 years, the Nifty Pharma index outperformed the Nifty 50 index by delivering a CAGR of 12.38%, compared to the Nifty 50 at 10.56%. The following are the benefits of investing in the Nifty Pharma index.
Pharma stocks are considered ‘Defensive’ in nature as the demand for medicines and healthcare is not influenced by economic conditions.
Investing in the Nifty Pharma index offers exposure to the top 20 companies in the sector and spreads your investments across these, reducing the risk of overreliance on a single or a few companies.
According to the Ministry of Finance, India is the third largest pharmaceutical producer in the world, with exports hitting USD 30.47 billion in 2024-25, 9.4% higher than the previous year. If the rupee weakens, the export-oriented companies would benefit significantly as they earn in dollars and spend in rupees.
The Nifty Pharma index funds or ETFs offer exposure to India’s one of the strongest sectors at a low entry cost since these funds have lower expense ratios as they are passively managed.
The pharma sector may offer high growth potential driven by an ageing population, increased healthcare spending, and medical technological advances, potentially leading to capital appreciation in the long-term.
Though the Nifty Pharma index delivered strong performance and may offer long-term capital appreciation, you must consider the following risks before investing in it.
Pharmaceutical companies are under strict oversight from bodies such as the USFDA (U.S. Food and Drug Administration), and any warning letters or import alerts issued by them can significantly impact a company’s stock price, thereby bringing down the index.
The generic drug market experiences high competition with domestic and US-based companies, reducing profit margins of companies and impacting the index’s performance.
Investing in a sectoral index can lead to concentration risk, where if the sector faces downturns, your investments would be significantly impacted.
Since the pharma sector is export-oriented, a strong rupee would significantly impact their revenue and profits.
Pharma companies invest heavily in R&D for producing new and better medicines, which don't always yield results. If investments into the company's clinical trials and R&D fail, it may drop stock prices significantly.
To maintain their competitive advantage, pharma companies need to procure patents for their products. If a patent expires and a competitor introduces a cheaper and similar product, the company’s revenue may be negatively impacted.
The Nifty Pharma index can offer capital appreciation to long-term investors seeking wealth creation opportunities. However, before investing, it is important to understand how and what factors impact the performance of the pharmaceutical sector to make informed investment decisions.
The Nifty Pharma index tracks the performance of the top 20 pharmaceutical companies listed on the NSE. These companies are selected based on the eligibility criteria set by the NSE Indices Ltd.
You can invest in the Nifty Pharma index by directly buying the individual stocks, or investing in index funds and ETFs. Before investing in the index, it is important to understand the risks associated and the factors impacting the sector to make informed investment decisions.
The Nifty Pharma index is a sectoral benchmark index that tracks the performance of the top 20 pharmaceutical companies listed on NSE.
There are 20 stocks in the Nifty Pharma Index.
The Nifty Pharma index is calculated using the free float market capitalisation method to derive the index value that reflects the total free float value of all the stocks relative to the base market capitalisation value.
The NSE Indices Ltd manages and rebalances the Nifty Pharma Index.
Yes, beginners with a long-term investment horizon can invest in the Nifty Pharma index, provided that they understand the factors impacting the sectors and the risk involved.
You can directly invest in the individual stocks listed in the index, or opt for passive investments such as Index funds and ETFs that replicate the index.
The Nifty Pharma index is significantly affected by factors such as currency fluctuations, high competition, macroeconomic factors, government regulations, and the cost of raw materials (Active Pharmaceutical Ingredients).
The Nifty Pharma index is rebalanced semi-annually to ensure the index accurately reflects the performance of the Indian pharmaceutical sector.
About Author
Mariyam Sara
Sub-Editor
holds an MBA in Finance and is a true Finance Fanatic. She writes extensively on all things finance whether it’s stock trading, personal finance, or insurance, chances are she’s covered it. When she’s not writing, she’s busy pursuing NISM certifications, experimenting with new baking recipes.
Read more from MariyamUpstox is a leading Indian financial services company that offers online trading and investment services in stocks, commodities, currencies, mutual funds, and more. Founded in 2009 and headquartered in Mumbai, Upstox is backed by prominent investors including Ratan Tata, Tiger Global, and Kalaari Capital. It operates under RKSV Securities and is registered with SEBI, NSE, BSE, and other regulatory bodies, ensuring secure and compliant trading experiences.
Share Market
What Is the Nifty PSU Bank Index? Beginner’s Guide to PSU Bank Investing6 min read | Written by Mariyam Sara
Share Market
What Is the Nifty Smallcap Index? Full Beginner’s Guide to Small-Cap Investing in India7 min read | Written by Mariyam Sara
Share Market
What Is the Nifty Midcap Index? Beginner’s Guide to Mid-Cap Investing in India6 min read | Written by Mariyam Sara
Share Market
What Is the Nifty Auto Index? Complete Sectoral Index Guide6 min read | Written by Mariyam Sara